CA46975-2A - 0x0000000000006921
Healthy Males & Females
Refresh
* Stipend may pay up to reflected amount.
Start Date:
January 26, 2026 - 2:00pm
End Date:
February 11, 2026 - 8:30am
Study Details
Study Number: CA46975
Group Number: 2A
Study Requirement: Healthy Normal Male and Female
Stipend: up to $5,500.00
Study Criteria
Age: 19 - 55
BMI: 18 - 32
Weight Restriction: minimum weight 0 lbs
Study Information
Indication: This investigational medication is being developed to treat of atopic dermatitis (AD).
Route of Administration: Oral
Blood Draws: 20
Study Schedule
Schedule Type: Long Term
Study Length: 9 Night Stay & 1 Return
Screening Dates:
| Event Day | Event Date |
|---|---|
| Monday | 1/19/2026 |
| Thursday | 1/22/2026 |
| Friday | 1/23/2026 |
| Monday | 1/26/2026 |
Doctor Exam Dates:
| Event Day | Event Date |
|---|---|
| Monday | 1/19/2026 |
| Thursday | 1/22/2026 |
| Friday | 1/23/2026 |
| Monday | 1/26/2026 |
Study Dates:
| Event Type | Start Day | Start Date | End Day | End Date | Phase | Site |
|---|---|---|---|---|---|---|
| Check-In | Monday | 1/26/2026 2:00:00 PM | Wednesday | 2/4/2026 8:45:00 AM | 1 | Lincoln |
| Return | Wednesday | 2/11/2026 7:30:00 AM | Wednesday | 2/11/2026 8:30:00 AM | 1 | Lincoln |
